DLR-Logo -> http://www.dlr.de
DLR Portal Home | Imprint | Privacy Policy | Contact | Deutsch
Fontsize: [-] Text [+]

Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension

Engeli, S. and Stinkens, R. and Heise, T. and May, M. and Goossens, G.H. and Blaak, E.E. and Jax, T. and Albrecht, D. and Pal, P. and Tegtbur, U. and Haufe, S. and Langenickel, T.H. and Jordan, J. (2018) Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension. Hypertension, 71 (1), pp. 70-77. American Heart Association, Inc.. doi: 10.1161/HYPERTENSIONAHA.117.10224. ISSN 0194-911X.

[img] PDF - Published version

Official URL: http://hyper.ahajournals.org


Sacubitril/valsartan (LCZ696), a novel angiotensin receptor-neprilysin inhibitor, was recently approved for the treatment of heart failure with reduced ejection fraction. Neprilysin degrades several peptides that modulate lipid metabolism, including natriuretic peptides. In this study, we investigated the effects of 8 weeks’ treatment with sacubitril/valsartan on whole-body and adipose tissue lipolysis and lipid oxidation during defned physical exercise compared with the metabolically neutral comparator amlodipine. This was a multicenter, randomized, double-blind, active-controlled, parallel-group study enrolling subjects with abdominal obesity and moderate hypertension (mean sitting systolic blood pressure ≥130–180 mmHg). Lipolysis during rest and exercise was assessed by microdialysis and [1,1,2,3,3-2H]-glycerol tracer kinetics. Energy expenditure and substrate oxidation were measured simultaneously using indirect calorimetry. Plasma nonesterifed fatty acids, glycerol, insulin, glucose, adrenaline and noradrenaline concentrations, blood pressure, and heart rate were also determined. Exercise elevated plasma glycerol, free fatty acids, and interstitial glycerol concentrations and increased the rate of glycerol appearance. However, exercise-induced stimulation of lipolysis was not augmented on sacubitril/valsartan treatment compared with amlodipine treatment. Furthermore, sacubitril/valsartan did not alter energy expenditure and substrate oxidation during exercise compared with amlodipine treatment. In conclusion, sacubitril/valsartan treatment for 8 weeks did not elicit clinically relevant changes in exercise-induced lipolysis or substrate oxidation in obese patients with hypertension, implying that ist benefcial cardiovascular effects cannot be explained by changes in lipid metabolism during exercise.

Item URL in elib:https://elib.dlr.de/124121/
Document Type:Article
Title:Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension
AuthorsInstitution or Email of AuthorsAuthor's ORCID iDORCID Put Code
Engeli, S.Hannover Medical School, Hannover, GermanyUNSPECIFIEDUNSPECIFIED
Stinkens, R.Department of Human Biology, NetherlandsUNSPECIFIEDUNSPECIFIED
May, M.Institute for Clinical Pharmacology, MHH, GermanyUNSPECIFIEDUNSPECIFIED
Goossens, G.H.Department of Human Biology, NetherlandsUNSPECIFIEDUNSPECIFIED
Blaak, E.E.Department of Human Biology, NetherlandsUNSPECIFIEDUNSPECIFIED
Albrecht, D.Translational Medicine Novartis, SwitzerlandUNSPECIFIEDUNSPECIFIED
Pal, P.Biostatistical Sciences, Novartis, IndiaUNSPECIFIEDUNSPECIFIED
Haufe, S.Hannover Medical School, Hannover, GermanyUNSPECIFIEDUNSPECIFIED
Langenickel, T.H.Translational Medicine, Novartis, SwitzerlandUNSPECIFIEDUNSPECIFIED
Jordan, J.Institute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.UNSPECIFIEDUNSPECIFIED
Journal or Publication Title:Hypertension
Refereed publication:Yes
Open Access:Yes
Gold Open Access:No
In ISI Web of Science:Yes
Page Range:pp. 70-77
Publisher:American Heart Association, Inc.
Keywords:exercise-induced lipolysis; hypertension; lipid metabolism; natriuretic peptide, neprilysin; obesity; sacubitril/valsartan
HGF - Research field:Aeronautics, Space and Transport
HGF - Program:Space
HGF - Program Themes:Research under Space Conditions
DLR - Research area:Raumfahrt
DLR - Program:R FR - Research under Space Conditions
DLR - Research theme (Project):R - Vorhaben Systemphysiologie (old)
Location: Köln-Porz
Institutes and Institutions:Institute of Aerospace Medicine > Cardiovascular Medicine in Aerospace
Deposited By: Schrage, Larissa
Deposited On:06 Dec 2018 14:20
Last Modified:08 Nov 2023 15:02

Repository Staff Only: item control page

Help & Contact
electronic library is running on EPrints 3.3.12
Website and database design: Copyright © German Aerospace Center (DLR). All rights reserved.